← Back to Analyst Consensus 
IMCR Buy
Immunocore Holdings plc
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 3, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Apr 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 16, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Feb 26, 2026 | Needham | maintain | Buy → Buy | $75 | 50% |
| Feb 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Nov 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $36 | 54% |
| Oct 31, 2025 | Wells Fargo | initiate | — → Overweight | $60 | 54% |
| Oct 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Jun 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 8, 2025 | Oppenheimer | maintain | Outperform → Outperform | $86 | 52% |
| Apr 14, 2025 | JP Morgan | maintain | Overweight → Overweight | $50 | 54% |
| Apr 10, 2025 | Needham | reiterate | Buy → Buy | $71 | 50% |
| Apr 7, 2025 | Mizuho | maintain | Neutral → Neutral | $33 | 52% |
| Mar 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Mar 12, 2025 | Needham | reiterate | Buy → Buy | $71 | 50% |
| Mar 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Feb 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Feb 27, 2025 | Needham | reiterate | Buy → Buy | $71 | 50% |
| Jan 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Jan 10, 2025 | Needham | reiterate | Buy → Buy | $71 | 50% |
| Dec 13, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $35 | 54% |
| Nov 11, 2024 | Mizuho | downgrade | Outperform → Neutral | $38 | 52% |
| Nov 7, 2024 | Needham | maintain | Buy → Buy | $71 | 50% |
| Oct 24, 2024 | UBS | initiate | — → Sell | $24 | 54% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Oct 11, 2024 | Morgan Stanley | maintain | Overweight → Overweight | $74 | 54% |
| Oct 7, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Sep 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Sep 17, 2024 | Needham | maintain | Buy → Buy | $78 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Aug 9, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $89 | 52% |
| Aug 9, 2024 | Barclays | maintain | Overweight → Overweight | $66 | 53% |
| Aug 9, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Jul 10, 2024 | JP Morgan | maintain | Overweight → Overweight | $66 | 54% |
| Jun 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Jun 3, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| May 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 29, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| May 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 24, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| May 13, 2024 | Mizuho | maintain | Buy → Buy | $88 | 52% |
| May 9, 2024 | Canaccord Genuity | maintain | Hold → Hold | $67 | 48% |
| May 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $100 | 44% |
| May 9, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Apr 29, 2024 | Leerink Partners | initiate | — → Outperform | $74 | 50% |
| Apr 23, 2024 | Guggenheim | reiterate | Buy → Buy | $92 | 52% |
| Apr 11, 2024 | Needham | reiterate | Buy → Buy | $81 | 50% |
| Mar 20, 2024 | JP Morgan | maintain | Overweight → Overweight | $70 | 54% |
Price Target Trend
May 13, 2026 Latest: $62.73 Oct 25, 2026
EPS Estimates
0q $-0.13
Lo: $-0.26 Hi: $0.00
12 analysts ▲1
0y $-0.04
Lo: $-0.46 Hi: $0.29
11 analysts ▲1
+1y $-0.77
Lo: $-3.89 Hi: $1.30
12 analysts ▲1
+1q $-0.18
Lo: $-0.53 Hi: $0.09
12 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days